Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC

A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors

NCT06101082 ·Status: RECRUITING ·Phase: PHASE1

A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

NCT04636762 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

NCT05615142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC

NCT06243679 ·Status: ACTIVE_NOT_RECRUITING

Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer

NCT05059951 ·Status: RECRUITING

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT02434614 ·Status: UNKNOWN ·Phase: PHASE3

Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

NCT05261438 ·Status: COMPLETED

Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer

NCT05387512 ·Status: COMPLETED

Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC

NCT07053215 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

NCT04137588 ·Status: UNKNOWN

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

NCT04684459 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors

NCT06658951 ·Status: RECRUITING ·Phase: NA

The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma

NCT06647836 ·Status: ENROLLING_BY_INVITATION

Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer

NCT02573506 ·Status: COMPLETED ·Phase: PHASE2

A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer

NCT04311034 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors

NCT04324372 ·Status: COMPLETED ·Phase: PHASE1

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

NCT06394427 ·Status: NOT_YET_RECRUITING

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer

NCT01054482 ·Status: UNKNOWN ·Phase: PHASE2

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

NCT03351842 ·Status: RECRUITING ·Phase: PHASE2

A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

NCT06323265 ·Status: RECRUITING

Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC

NCT06532591 ·Status: RECRUITING ·Phase: PHASE2

Microtransplantation for Advanced and Relapsed Solid Tumors

NCT04937842 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB

NCT05295212 ·Status: RECRUITING ·Phase: PHASE2

A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

NCT02734524 ·Status: UNKNOWN ·Phase: PHASE2

Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

NCT03432598 ·Status: COMPLETED ·Phase: PHASE2